Department of Dermatology, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
Contact Dermatitis. 2023 Feb;88(2):120-128. doi: 10.1111/cod.14231. Epub 2022 Oct 11.
Allergic contact dermatitis (ACD) in paediatric patients is on the rise. Continuous identification of emerging allergens is of great importance to ensure accurate patch testing.
To assess the frequency and relevance of contact sensitivity in children and adolescents and evaluate changes in sensitization rates in the last decade.
All patients with suspected ACD who underwent patch testing at the Amsterdam University Medical Centers between 2015 and 2021 were included.
Of 439 patients tested with the European Baseline Series (EBS) and additional series, 334 (76%) patients had at least 1 positive reaction and 172 patients (39%) had 1 or more relevant positive reactions. If additional series would have been omitted, 20% of patients would have been underdiagnosed. Compared to patients tested between 1996 and 2013, reactions to metal allergens, isothiazolinones, methyldibromo glutaronitrile, carba mix, amerchol L-101, and benzophenone-4 were more frequently observed.
This study confirms the need for patch testing in paediatric patients suspected of having ACD. For accurate patch testing, it is advised to include additional series.
儿童过敏性接触性皮炎(ACD)的发病率呈上升趋势。不断发现新的过敏原对于确保准确的斑贴试验非常重要。
评估儿童和青少年接触敏感性的频率和相关性,并评估过去十年中致敏率的变化。
纳入 2015 年至 2021 年在阿姆斯特丹大学医学中心进行斑贴试验的疑似 ACD 的所有患者。
在接受欧洲基础系列(EBS)和其他系列斑贴试验的 439 名患者中,334 名(76%)患者至少有 1 个阳性反应,172 名(39%)患者有 1 个或更多相关的阳性反应。如果省略其他系列,20%的患者可能会漏诊。与 1996 年至 2013 年接受测试的患者相比,金属过敏原、异噻唑啉酮、甲基二溴戊二腈、卡巴混合物、amerchol L-101 和二苯甲酮-4 的反应更为常见。
本研究证实了对疑似患有 ACD 的儿科患者进行斑贴试验的必要性。为了进行准确的斑贴试验,建议包括其他系列。